A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
PHASE1RecruitingINTERVENTIONAL
Enrollment
20
Participants
Timeline
Start Date
October 31, 2025
Primary Completion Date
May 3, 2027
Study Completion Date
May 3, 2027
Conditions
Moderate to Severe Plaque PsoriasisPsoriatic ArthritisAxial SpondyloarthritisHidradenitis Suppurativa
Interventions
DRUG
Bimekizumab
Bimekizumab under the care of their treating physician.
Trial Locations (1)
Unknown
RECRUITING
Up0122 202, Calgary
All Listed Sponsors
lead
UCB Biopharma SRL
INDUSTRY
NCT06888193 - A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab) | Biotech Hunter | Biotech Hunter